LFVN — Lifevantage Corporation

Is LFVN overbought or oversold? Here is the current MarketMoodz read.

Consumer Defensive · Packaged Foods

Oversold As of November 17, 2026

Lifevantage Corporation (LFVN) currently reads Oversold on the MarketMoodz overbought/oversold meter, as of November 17, 2026. The Consumer Defensive name (Packaged Foods) last closed at $4.77. The rating moved from Strong Oversold to Oversold on November 17, 2026.

See all oversold Consumer Defensive stocks →

AI analysis

Lifevantage Corporation (LFVN) is a small-cap consumer health company whose near-term performance depends on product traction, distributor/channel execution and resolution of recent negative social/filing sentiment. The macro market environment is currently supportive of growth names and earnings-driven moves, which could provide short-term upside on positive company news. However, limited recent filing detail increases uncertainty; regulatory/disclosure questions, reputation effects from social sentiment, and competition create meaningful downside risks. Monitor upcoming earnings, any corrective SEC disclosures, and distributor engagement metrics for clearer directional signals.

Key factors

  • Lifevantage Corporation (LFVN) operates in consumer health/nutraceuticals where brand, product innovation and direct/independent distributor channels drive revenue volatility.
  • Recent social/SEC filing sentiment has been negative, indicating short-term reputational or disclosure concerns that can affect investor confidence.
  • Broader market tone is cautiously optimistic and earnings-driven, which may provide episodic support around positive results or guidance beats.
  • Limited available recent EDGAR comparisons in the provided data increases uncertainty around current financial trends and makes near-term fundamental assessment dependent on public commentary and earnings.
  • Company performance is sensitive to consumer discretionary spending and marketing/distribution effectiveness; modest improvements in product traction could lift results.
  • Liquidity and float size typical of small-cap consumer names can amplify share moves on news or social sentiment.

Risks

  • Regulatory or disclosure issues tied to SEC filings or compliance that could trigger investor concern or additional scrutiny.
  • Revenue and margin volatility from reliance on direct-sales/distributor models and product cycle success.
  • Reputational risk from negative social media narratives that can suppress demand or distributor enthusiasm.
  • Competitive pressure from larger, better-capitalized health and wellness brands reducing market share or forcing higher marketing spend.
  • Supply-chain cost fluctuations or fulfillment constraints that compress margins or delay product availability.
  • Limited public financial transparency in the short window provided increases the chance of unexpected earnings surprises.
  • Low liquidity and concentrated ownership raising downside volatility on negative news.

See today's live rating, score and targets

Members see the live hourly rating for LFVN — the numeric AI score plus targets and entry zones — while this public page updates nightly.

Start the 14-day trial

This page is for informational purposes only and is not investment, financial, tax, or legal advice. Ratings and research outputs can be wrong, incomplete, or stale. Past performance does not guarantee future results. Always do your own research and consider consulting a qualified professional.